Contact: Cindy Hoang, National Consumers League, (202) 207-2832, cindyh@nclnet.org
Washington, DC—The National Consumers League (NCL) today declared its deep disappointment in President Donald Trump’s announcement that he will end the Dreamers Program. Known officially as the “Deferred Action for Childhood Arrivals (DACA),” the program was adopted during former President Barack Obama’s Administration to create a citizenship path for young people brought to the United States at a young age by their parents. The process of citizenship through DACA is a lengthy one, including requirements of having no criminal record and either being enrolled in school or employed. DACA registrants are eligible for work permits during their two-year period of deferment, and other guidelines for qualification for the program.
The following quote may be attributed to NCL Executive Director Sally Greenberg:
“The National Consumers League adopted policy in support of immigration reform several years ago because it fits well within our mission of protecting vulnerable populations from consumer and employer exploitation. The Dreamers contribute an estimated 2 billion dollars a year to our tax base, and deporting them would cost an estimated $400 billion. As of March 2017, there are more than 800,000 people who will be affected by the termination of this program.”
“These young people are also consumers who have contributed to the country’s economy. As a consumer advocacy organization, the National Consumers League cannot endorse the decision by President Trump to put an end to DACA.”
“Even more disturbing is the threat of using personal information submitted in the vetting process to find and deport DACA protected workers. This is the wrong message to send to outstanding young people who, through no fault of their own, have grown up in this country under the shadow of deportation.”
###
About the National Consumers League
The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.
https://nclnet.org/wp-content/uploads/2020/08/NCL-logo.png00Melody Merinhttps://nclnet.org/wp-content/uploads/2020/08/NCL-logo.pngMelody Merin2017-09-11 18:42:242020-12-14 21:48:06President Trump’s attack on DACA gives Americans reason to worry – National Consumers League
National student financial literacy competition opens 2017-18 season
Contact: Cindy Hoang, NCL Communications, (202) 207-2832 or cindyh@nclnet.org
Washington, DC–Today marks the official launch of the 24th season of LifeSmarts, with a new competition going live at the online home of the program, LifeSmarts.org. LifeSmarts, a program of the National Consumers League (NCL), is a national scholarship competition and educational program for middle-school and high-school students that tests knowledge of real-life consumer issues and aims to create a future generation of consumer-savvy adults.
“We are very excited to launch our 24th season of LifeSmarts,” said national Program Director Lisa Hertzberg. “LifeSmarts gives students the skills they need to succeed as adults. We see students gain knowledge, confidence, leadership capabilities, and team-building skills. The competition is a lot of fun, and the impact of LifeSmarts is lifelong.”
LifeSmarts focuses on five main content areas: consumer rights and responsibilities, personal finance, technology, health and safety, and the environment. Students are quizzed on their knowledge of these subject areas during online competition. Top-performing teams then advance to statewide competitions, and state champion teams advance to the national championship held each year in a different American city. The 2018 National LifeSmarts Championship will take place April 21-24 in San Diego. Winning team members receive scholarships and other prizes.
Last year, students answered more than 3.5 million consumer questions about credit reports, recycling, nutrition, social media, state lemon laws, and everything in between. By being consumer savvy and quick on the buzzers, the LifeSmarts team from Dallas High School in Dallas, PA, took home top honors at the 23rd national event in Pittsburgh, PA. Dallas High was a returning champion, taking home the national title two years in a row.
In addition to state and national competitions, LifeSmarts recognition and awards occur throughout the program year:
Teams of students vie for cash prizes in the online TeamSmarts quiz, which focuses on a specific LifeSmarts content area each month from September through January.
Five $1,000 scholarships are awarded each winter to winning LifeSmarts students who become Safety Smart Ambassadors, using LifeSmarts content to present safety messages to younger children in their communities.
Partnering with FBLA (Future Business Leaders of America) and FCCLA (Family, Career, and Community Leaders of America), LifeSmarts offers special competitive events for student members of both student leadership organizations. FBLA and FCCLA team members have the opportunity to compete for cash prizes, trophies, and other honors.
LifeSmarts is active in all states and the District of Columbia, where NCL is headquartered. During the 2016-17 program year, when a team from Kodiak, AK, signed up, LifeSmarts reached its 50th state.
“We are excited to continue to grow the LifeSmarts program into new states and regions, to continue to educate students about financial literacy, and to create a new generation of savvy, market-ready consumers and workers,” said Sally Greenberg, executive director of NCL. “Too often traditional high school curriculum fails to teach students vital information that will be crucial once students go to college, get their first job, or move out of their parents’ house.”
In addition to hosting the official LifeSmarts competition, LifeSmarts.org provides resources for teachers to supplement existing lesson plans. These include daily quizzes, educational videos, social media competitions, focused study guides, and scholarship opportunities. LifeSmarts lessons closely align with courses taught in family and consumer sciences, business, technology, health, and vocational education. Math and English teachers have also had success with LifeSmarts, as have homeschool and community educators.
Major LifeSmarts contributors include: McNeil Consumer Healthcare, Johnson & Johnson, LifeLock, Underwriters Laboratories, Western Union, Comcast NBC Universal, Experian, Intuit, American Express Company, and others.
Visit LifeSmarts.org for more information.
LifeSmarts: Learn it. Live it.
###
About LifeSmarts
LifeSmarts is a program of the National Consumers League. State coordinators run the programs on a volunteer basis. For more information, visit: LifeSmarts.org, email lifesmarts@nclnet.org, or call the National Consumers League’s communications department at 202-835-3323.
The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.
https://nclnet.org/wp-content/uploads/2020/08/NCL-logo.png00Melody Merinhttps://nclnet.org/wp-content/uploads/2020/08/NCL-logo.pngMelody Merin2017-09-11 14:44:002020-12-14 21:48:06LifeSmarts is back! Launching 2017-2018 season of education and scholarship program
Contact: Cindy Hoang, National Consumers League, (202) 207-2832, cindyh@nclnet.org Congressional action in response to 143 million-record breach is long overdue, says consumer group
Washington, DC—Equifax, one of the nation’s three major credit bureaus has announced that 143 million consumers have had their personally identifiable information compromised. The following statement is attributable to John Breyault, National Consumers League Vice President of Public Policy, Telecommunications and Fraud:
“In a scenario that has become all too common, a company entrusted with protecting consumers’ most sensitive data has failed to protect that data. While Equifax will face a public relation headache, it is the consumers who will ultimately pay the price in the form of higher risk of identity theft and other fraud.
Even worse, Equifax adds insult to injury by requiring consumers to waive their right to a day in court and accept mandatory binding arbitration in order to take advantage of the company’s free year of credit monitoring. Cybersecurity experts estimate that the effects of this breach may be felt by consumers for decades. Consumers who choose to take advantage of Equifax’s credit monitoring in response to this breach should be sure to read the fine print carefully to find out how to opt out of these outrageous arbitration clauses.
The time is long overdue for Congress to step in and pass comprehensive data security legislation. This legislation should not only outline strong data security practices, but also minimum responsibilities for companies to compensate affected consumers when their personal information is exposed.”
For additional information on this breach and what consumers can do to protect themselves, visit Fraud.org’s “Data Breach HQ” page on the breach here.
###
About the National Consumers League
The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.
https://nclnet.org/wp-content/uploads/2020/08/NCL-logo.png00Melody Merinhttps://nclnet.org/wp-content/uploads/2020/08/NCL-logo.pngMelody Merin2017-09-08 20:01:092020-12-14 21:48:06Equifax adds insult to injury by requiring consumers affected by data breach to agree to mandatory binding arbitration – National Consumers League
On behalf of our consumer, public health and safety organizations, we would like to provide our views of H.R. 3388, the Safely Ensuring Lives Future Deployment and Research In Vehicle Evolution Act (SELF DRIVE Act). This legislation addresses the future development and deployment of autonomous vehicles (AVs) and will be considered by the House of Representatives tomorrow.
Unfortunately, this legislation takes an unnecessary and unacceptable hands-off approach to hands-free driving. A recent study conducted by the Massachusetts Institute of Technology revealed deep public skepticism about AVs. Only 13 percent of those polled reported that they would be comfortable with vehicle “features that completely relieve the driver of all control for the entire drive.” Similarly, a Kelly Blue Book survey, released in September 2016, found that nearly 80 percent of respondents believed that people should always have the option to drive themselves, and nearly one in three said they would never buy a level 5 AV.
Any defect or setback involving AVs will severely curtail public acceptance of this technology and risk the progress and promise AVs hold to significantly reduce motor vehicle crashes, fatalities and injuries. For these reasons, the following issues must be adequately addressed to ensure public safety, security and confidence.
Excessive Numbers of Exempted Vehicles are Permitted and will Jeopardize Safety: Expanding statutory exemptions from the Federal Motor Vehicle Safety Standards (FMVSS) for AVs is both unwarranted and unwise. As currently drafted, the bill would allow for potentially millions of vehicles on America’s roads that have been exempted from critical FMVSS including those that apply to occupant protection and crashworthiness. Only 18 months ago, Congress increased allowable exemptions for manufacturers in the FAST Act (Pub. L. 114-94), and this is sufficient for the development and deployment of AVs.
Exemptions from Crashworthiness Standards Should be Prohibited: Any provision allowing for exemptions from crashworthiness standards, no matter the qualification or time line, is an egregious and unacceptable attack on safety. Autonomous vehicles will be sharing the roads with traditional vehicles for many years to come and will undoubtedly be involved in crashes. Exposing motorists to the dangers of crashes without proven and needed protections is a wanton disregard for public health and safety.
Essential Data and Public Information About AVs are Needed: The National Highway Traffic Safety Administration (NHTSA) should be required to establish and maintain a current public database for all AVs that contains essential data including but not limited to Safety Assessment Letters, information on the level of automation of each vehicle, exemptions from FMVSS that it is operating under, and the operational design domain with which the AV is equipped. The data collected in the database shall be appended to crash databases maintained by the U.S. Department of Transportation. Such a database will allow for independent evaluation and research on the real-world performance of AVs. Furthermore, all non-proprietary communications and responses between the agency and a manufacturer as it relates to any issues involving AVs must be made available for contemporaneous public review, scholarly research and safety analysis by independent stakeholders.
Finally, Congress must ensure that consumers are given essential information about an AV. Under the current version of this bill, it will be years before NHTSA even completes research before beginning the process to issue a consumer information rule. Every manufacturer should be required to provide every consumer for every vehicle sold information about its capabilities, limitations and exemptions from federal safety standards. This information should not be withheld from consumers until NHTSA completes research and finally issues a rule.
Sufficient Funding for NHTSA is Critical: The agency must be given additional funding and staff resources in order to meet the demands being placed on the agency with regard to the advent of AV technology. We recommend the establishment of an office of AV technology within NHTSA with an adequate budget to implement the requirements of this legislation, to assist in the safe introduction of AV technology into the marketplace, and to ensure oversight and accountability.
NHTSA Needs Additional Enforcement Powers: NHTSA should be given the additional tools of imminent hazard authority to protect against potentially catastrophic defects with AVs and criminal penalties to ensure manufacturers do not willfully and knowingly put defective AVs into the marketplace.
State Preemption is Too Broad: We share the concerns expressed by associations representing Governors, state legislators and other state officials about the broad and unacceptable preemption language in H.R. 3388. While we support the statutory mission of NHTSA to regulate the design and performance of motor vehicles to ensure public safety, unless and until NHTSA issues comprehensive standards and regulations to govern AVs, states have every legal right, indeed a duty to their citizens, to fill the regulatory vacuum with state developed proposals and solutions for ensuring public safety. States must not be precluded from fulfilling their role to protect their citizens.
It is critically important that life-saving technologies be advanced in a safe and expeditious manner. We believe that AVs will not only change our lifestyles but may, once and for all, change our ability to achieve meaningful and lasting reductions in the death and injury toll on our streets and highways. However, realizing these goals can only be achieved if Congress enacts legislation that ensures that AVs are developed and deployed in a safe, sensible and transparent manner.
Sincerely,
Jacqueline Gillan, President Advocates for Highway and Auto Safety
Joan Claybrook, Chair Citizens for Reliable and Safe Highways and Former Administrator, NHTSA
Jason Levine, Executive Director Center for Auto Safety
Jack Gillis, Director of Public Affairs Consumer Federation of America
Sally Greenberg, Executive Director National Consumers League
Andrew McGuire, Executive Director Trauma Foundation
John Lannen, Executive Director Truck Safety Coalition
https://nclnet.org/wp-content/uploads/2020/08/NCL-logo.png00Melody Merinhttps://nclnet.org/wp-content/uploads/2020/08/NCL-logo.pngMelody Merin2017-09-06 18:24:002020-12-14 18:23:45Advocates’ joint letter on autonomous vehicle legislation being considered by the House – National Consumers League
Contact: Cindy Hoang, National Consumers League, (202) 207-2832, cindyh@nclnet.org
Washington, DC—Today the National Consumers League (NCL), the nation’s pioneering consumer advocacy organization, is expressing extreme disappointment that the Trump Administration is yet again undermining the Affordable Care Act (ACA), despite Obamacare’s popularity nationwide across all income and geographic lines.
The Administration has:
Cut the 2018 Open Enrollment Period for the Health Insurance Marketplace in half. It now runs only from November 1, 2017 to December 15, 2017, instead of remaining open until January 31, 2018.
Cut the ACA’s advertising budget to promote the Open Enrollment Period from $100 million to $10 million. Adding insult to injury, the Affordable Care Act Navigator program will be cut by nearly $30 million — from $62.5 million to $36 million. Navigators are critical to helping consumers to choose and enroll in Marketplace coverage.
The following statement may be attributed to Sally Greenberg, NCL executive director:
“NCL is extremely disappointed in the Trump Administration’s undermining of the ACA Marketplace. Millions of Americans need and depend on access to health care to keep themselves and their families healthy. Millions more are eligible to sign up for ACA coverage. Rather than acting to stabilize the health care marketplace and help people get the care they need, the Trump Administration’s actions guarantee reduced enrollment. This goes directly against the wishes of the vast majority of the American people. Seven in 10 Americans would rather see Congress make improvements to the ACA—not try to destroy it.Congress has tried numerous times to repeal and replace the law, but it keeps failing because Americans don’t want it repealed. Despite what President Trump might say, any failure of the ACA Marketplace will fall squarely upon his shoulders.
To address this large gap in advertising funding, the National Consumers League is joining with our colleagues in the health advocacy community to urge consumers to enroll in health coverage by the December 15, 2017 deadline. NCL will also work with our allies to encourage Congress to act to shore up the marketplace.”
###
About the National Consumers League
The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.
https://nclnet.org/wp-content/uploads/2020/08/NCL-logo.png00Melody Merinhttps://nclnet.org/wp-content/uploads/2020/08/NCL-logo.pngMelody Merin2017-09-06 14:04:512020-12-14 21:48:06NCL: Trump Administration sabotage of Affordable Care Act is inexcusable – National Consumers League
With heartbreaking images of the recent devastation in Houston, many consumers in the United States and around the world are reaching for their wallets to help. The inclination to send donations is generous and kind, but advocates know that con artists have long exploited natural disasters, and consumers must be careful in order to avoid sending money to scammers who pose as charities.
In the days following a natural disaster, our Fraud.org staff often hear from consumers about crooks’ attempts to take advantage of tragic events for their personal gain. After the September 11 terrorist attacks, Hurricane Katrina, and the 2010 earthquake in Haiti, we received reports of a variety of scams tailored by con artists to capitalize on the rescue efforts. Scams typically involve con artists sending out emails purporting to come from a known and respected charity such as the Red Cross or Oxfam International. Victims are then directed to a fake Web site made to look like a legitimate charity’s site, where they are asked to share personal information or donate via wire transfer, PayPal, or a bank account. The scammer then makes off with the donation, and no real funds are sent to support actual disaster relief.
“The continued tragedy of fraud perpetrated in the wake of such disasters is that charity scams not only rob the donors,” said John Breyault, NCL vice president for public policy on telecommunications and fraud. “They also divert contributions from legitimate charities, who are in great need for money and goods to assist those who need it most.”
Fraudulent charities use natural disasters like the one in Houston to trick people who want to aid the victims. If you’re not sure whether a charity is legitimate, follow this advice:
If you’re approached by an unfamiliar charity, check it out. Most states require charities to register with them and file annual reports showing how they use donations. Ask your state or local consumer protection agency how to get this information. The Better Business Bureau Wise (BBB) Giving Alliance also offers information about national charities. Call (703) 276-0100 or go to Give.org.
Ask for written information. Legitimate charities will be happy to provide details about what they do and will never insist that you act immediately.
Beware of sound-alikes. Some crooks try to fool people by using names that are very similar to those of legitimate, well-known charities.
Ask about the caller’s relation to the charity. The caller may be a professional fundraiser, not an employee or a volunteer. Ask what percentage of donations goes to the charity and how much the fundraiser gets.
Be wary of requests to support police or firefighters. Some fraudulent fundraisers claim that donations will benefit police or firefighters, when in fact little or no money goes to them. Contact your local police or fire department to find out if the claims are true and what percentage of donations, if any, they will receive.
https://nclnet.org/wp-content/uploads/2020/08/92_donate.jpg9292Melody Merinhttps://nclnet.org/wp-content/uploads/2020/08/NCL-logo.pngMelody Merin2017-09-05 17:39:132020-10-16 18:49:02Hurricane Harvey charity scams warning – National Consumers League
PBPA Commends HHS Funding to Support Maternal and Infant Health
The Preterm Birth Prevention Alliance (PBPA), a coalition of maternal and women’s health advocates dedicated to improving preterm birth outcomes in the United States and addressing its disproportionate impact on women of color, applauds the U.S. Department of Health and Human Services (HHS) for awarding nearly $350 million to states across the country to improve support for safe pregnancies and healthy babies.
“For far too long, U.S. maternal health care has lagged behind that of other developed countries, particularly for women of color,” noted Sally Greenberg, Executive Director of the National Consumers League. “This additional funding will enable local health departments and nonprofits to better address the health care needs of the most vulnerable mothers and their babies.”
The funding, awarded by HHS’ Health Resources and Services Administration (HRSA), will support home visiting services, increase access to doulas, address infant mortality and maternal illness, and improve data reporting on maternal mortality.
“Maternal health care in the U.S. has consistently failed women of color,” Greenberg continued. “We applaud HHS for this additional funding that will help to improve the maternal health for all mothers and babies, especially women of color and those most at-risk.”
The funding announcement follows the release of a report by the U.S. Commission on Civil Rights which found that Native American women are more than two times more likely to die from pregnancy-related complications than white women in the U.S. This disparity was further exacerbated for Black women in the U.S., who are three to four times more likely to die from pregnancy-related complications than white women.
“In addition to expanding programs to support maternal health, we must increase representation from racially and ethnically diverse groups in research and clinical trials, particularly those studying treatment options to prevent maternal morbidity and mortality,” said Greenberg. “The need for the additional HHS funding and the report from the Commission on Civil Rights clearly illustrate how critical representative research and real world evidence are to ensuring all mothers and their babies have the same opportunity for the best possible health outcomes.”
While the COVID-19 pandemic has led to hardship for all Americans, it is clear that people of color have been disproportionately burdened. Across the health care continuum, addressing this disparity has become part of the broader conversation about the history of systemic racism and the underlying social determinants of health that negatively affect the mental, physical, and economic health of individuals and entire communities.
The pandemic has underscored persistent health disparities, and there is growing recognition that representation in research and clinical trials can have a profound impact on health outcomes. A lack of representation from racially and ethnically diverse groups in research and clinical trials have typically led to gaps in data, missing the opportunity to assess the full impact of various treatments and drugs across a range of populations. The collection and use of real-world research and data to inform the potential use, risks, and benefits of medical products and treatments can ultimately lead to better health outcomes, particularly for those who have been underrepresented in the past.
Existing efforts to improve inclusion
Efforts to expand diversity and representation in medical research are underway in Congress. Policymakers are encouraging the incorporation of Real World Evidence (RWE) in drug development through the recent Cures 2.0 draft legislation released by Reps. Diana Degette (D-CO-1) and Fred Upton (D-MI-6). While the status quo limits us from effectively reaching underserved populations, the proposed legislation would allow studies that include RWE for some drugs after they have been approved. At the heart of this issue is a growing appreciation that the same therapy can affect different populations in different ways, which is why Cures 2.0 supports collecting data that more accurately reflects the unique experiences and needs of patients across diverse populations.
Recognizing the potential for RWE in maternal health
The lack of representative research in the field of maternal health is undeniable, and its implications are staggering. The dismal state of maternal care in the United States reflects how our health care system has failed women of color, including by not adequately studying treatment options to prevent maternal morbidity and mortality. The need for RWE is clear when you consider the persistent disparities in health outcomes that plague minority communities.
Preterm birth and its disproportionate impact on women of color is a stark illustration of the need to make progress on representative research in maternal health. Preterm birth is the second-largest contributor to infant death in America today. Despite the tremendous physical, emotional, and financial toll that preterm birth continues to take on our country — disproportionately so on women and families of color — not enough therapeutic tools currently exist to prevent it.
Today, “17P,” the only FDA-approved treatment to help reduce the likelihood of spontaneous, recurrent preterm birth in the United States is at-risk of being withdrawn from the market in all its forms, including the branded product and five generic versions. Unfortunately there is conflicting evidence from two different clinical trials, one representative of a diverse U.S. population and another studied in a largely white population in Europe. It’s not a straightforward comparison. If 17P is withdrawn, the women most affected by preterm birth, predominantly women of color, would be left without an FDA-approved treatment option.
The FDA is considering the path forward, including additional data collection through leveraging RWE from past patient use. The success of the first (approval) trial for 17P in the impacted communities signals the importance of RWE. Continued access to 17P is, at its core, a matter of health equity. Black women must not yet again be left vulnerable to a system that historically has overlooked them.
PRETERM BIRTH PREVENTION ALLIANCE APPLAUDS FDA’S GRANTING OF HEARING FOR THE ONLY FDA-APPROVED THERAPIES TO REDUCE RECURRENT PRETERM BIRTH
WASHINGTON, DC, August 26, 2021 –
Preterm Birth Prevention Alliance a coalition of maternal and women’s health advocates dedicated to improving preterm birth outcomes in the United States and addressing its disproportionate impact on women of color, commends the U.S. Food and Drug Administration (FDA) for granting a public hearing to discuss 17P, the only FDA-approved class of branded and generic treatments to reduce preterm birth in indicated patients.
We appreciate the FDA’s willingness to hear directly from individuals facing prematurity and the providers who treat them about their experiences with 17P,” said National Consumer League’s Executive Director Sally Greenberg. “It is an important step towards better understanding variations in efficacy across diverse populations and ensuring all women have an equal chance at the best possible outcomes.”
Last week, the FDA agreed to grant Covis Pharma, the manufacturer of the branded 17P product Makena its request for a public hearing to discuss 17P. Hydroxyprogesterone caproate—or “17P”—has been approved since 2011 and is the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth in the United States. In 2020, the FDA proposed withdrawing 17P in all its forms, including the branded product and its five generic versions, based on conflicting efficacy data from two studies composed of vastly different populations, one predominantly inclusive of women in the U.S. most vulnerable to preterm birth and one not.
“Mothers and birthing people deserve access to the best possible treatments to prevent preterm birth. We cannot achieve birth equity if we study pregnant women as a monolith,” said Blythe Thomas, Initiative Director of 1,000 Days. “It is only by systematically researching the real-world, post-market impact of 17P on individuals from a variety of racial and ethnic backgrounds, while maintaining access for all affected, that we can reduce disparities in maternal and infant health.”
While the hearing date has not yet been set, the Alliance looks forward to sharing the perspectives of affected individuals and their physicians with the agency once the hearing is scheduled and will continue to advocate for at-risk moms and babies of all races and ethnicities.
###
ABOUT THE PRETERM BIRTH PREVENTION ALLIANCE
The Preterm Birth Prevention Alliance (PBPA) is a coalition of maternal and women’s health advocates who share a common concern about the state of preterm birth in the United States and the proposed market withdrawal of 17P, the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth. Formed in 2021 by the National Consumers League, the 15 partners in the PBPA seek to improve preterm birth outcomes in the United States by maintaining access to safe, FDA-approved treatment options and advocating for more diverse medical research that adequately represents the experiences of women and newborns of color. Women of color need a seat at the table. To learn more, visit www.pretermbirthalliance.org
LEADING PATIENT ADVOCATES LAUNCH PRETERM BIRTH PREVENTION ALLIANCE TO PROTECT CRITICAL ACCESS TO THE SOLE FDA-APPROVED CLASS OF THERAPIES TO REDUCE RECURRENT PRETERM BIRTH
WASHINGTON, DC, April 20, 2021 – Today, the National Consumers League (NCL), along with a coalition of patient advocacy organizations dedicated to advancing the health of mothers and infants, announced the launch of the >Preterm Birth Prevention Alliance.
Members of the Alliance are joining forces in an effort to preserve patient access to the only Food & Drug Administration-approved class of treatments for pregnant women who have previously had an unexpected, or spontaneous, preterm birth. Together, Alliance members seek to ensure that the Food & Drug Administration (FDA) hears concerns from the full range of stakeholders about the potential risks and impact of withdrawal for at-risk pregnant women and their providers.
For the fifth year in a row, the U.S. preterm birth rate has increased (to 10.2 percent of births), and preterm birth and its complications were the second largest contributor to infant death across the country. Preterm birth also represents a significant racial health disparity, with Black women in America experiencing premature delivery at a rate 50 percent higher than other racial groups throughout the country.
However, in 2020, the FDA >proposed withdrawing hydroxyprogesterone caproate, commonly called “17P” or “17-OHPC”, the only FDA-approved class of branded and generic treatments to help prevent the risk of preterm birth in women with a history of spontaneous preterm birth. The FDA is currently determining whether to hold a hearing on the status of 17P, based on conflicting efficacy data from two studies composed of vastly different patient populations, one inclusive of women in the U.S. most vulnerable to preterm birth and one not.
“We’re fighting for a more inclusive healthcare system that gives everyone an equal chance to have the best outcomes possible,” said Sally Greenberg, executive director of the National Consumers League. “We don’t believe that removing 17P from the market without gaining a better understanding of who could benefit the most from its use is in the best interests of patients, nor their healthcare providers, particularly as there are no other approved treatment options available.”
To date, 14 organizations have joined NCL to advocate for the health interests of at-risk pregnant women and infants, including: 1,000 Days; 2020 Mom; American Association of Birth Centers; Black Mamas Matter Alliance; Black Women’s Health Imperative; Expecting Health; Healthy Mothers, Healthy Babies Montana; HealthyWomen; Miracle Babies; National Birth Equity Collaborative; National Black Midwives Alliance; National Partnership for Women & Families; Sidelines High-Risk National Support Network; and SisterReach.
“As a trained obstetrician and gynecologist, I know firsthand the impact of preterm birth on Black women and birthing people. I also know that racism – not race – is the driving factor leading the disproportionate impact of preterm birth on Black women and birthing people thereby exacerbating systemic inequities in maternal and infant health. To achieve birth equity, which is the assurance of the conditions of optimal births for all people with a willingness to address racial and social inequities in a sustained effort, we must work to protect and uphold a standard of care for spontaneous, recurrent preterm births and ensure it remains accessible and affordable for all who stand in need,” added Dr. Joia Crear Perry, founder and president of the National Birth Equity Collaborative.
The Preterm Birth Prevention Alliance is calling for the FDA to grant a public hearing to fully consider all of the data, additional research methods, and stakeholder perspectives before deciding whether to withdraw approval of this critical class of therapies. The health of America’s moms and babies warrants the utmost care and consideration.
###
ABOUT THE PRETERM BIRTH PREVENTION ALLIANCE
The Preterm Birth Prevention Alliance is a coalition of maternal and women’s health advocates who share a common concern about the state of preterm birth in the United States and the proposed market withdrawal of 17P, the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth. Formed in 2021 by the National Consumers League, we seek to improve preterm birth outcomes in the United States by maintaining access to safe, FDA-approved treatment options and advocating for more diverse medical research that adequately represents the experiences of women and newborns of color. Women of color need a seat at the table. To learn more, visit www.pretermbirthalliance.org.
Initial support for the Preterm Birth Prevention Alliance is provided by Covis Pharma.
